Conditions | Metabolic parameter | Calculated parameter | Controls (n = 8) | PCOSr (n = 8) | p |
---|---|---|---|---|---|
Duration of follow-up (years) | 5.4 (5.3–6.0) | 5.6 (4.6–6.6) | 1.000 | ||
Anthropometric measures | Adiposity | BMI Z-score | 0.81 (−0.19–1.32) | −0.08 (−0.43–0.17) | 0.105 |
WHtR Z-score | 0.50 (−0.18–1.07) | −0.43 (−0.93–0.21) | 0.050 | ||
OGTT | Insulin sensitivity | ISIMatsuda | −7.7 (−12.2 – −2.2)a | −0.7 (−3.9–2.5) | 0.050 |
β-cell function | DIOGTT | −4.0 (−8.6 – −1.4)a | 0.2 (−1.6–3.4) | 0.010* | |
NEFA suppressibility | Logn-linear slope | 0.023 (0.016–0.027)a | −0.006 (−0.014 – −0.001)a | 0.001 | |
T50NEFA (min) | 18.2 (3.4–33.5)a | 10.5 (−0.6–17.4) | 0.161 | ||
FSivGTT | Insulin sensitivity | ISFSivGTT | −7.3 (−11.6 – −4.6)a | −0.5 (−2.0–0.3) | 0.001* |
Insulin secretion | AIRg | 274 (89–506)a | 190 (56–328)a | 0.442 | |
β-cell function | DIFSivGTT | −689 (−1693 – −333)a | 614 (−151–1233) | 0.003* | |
NEFA suppressibility | Logn-linear slope | 0.015 (0.003–0.033) | −0.001 (−0.067–0.012) | 0.083 | |
T50NEFA (min) | 9.6 (3.0–13.9)a | −1.3 (−6.0–6.5) | 0.065 |